Finkelstein Thompson LLP Announces Investigation of Metropolitan Health Networks, Inc.
The law firm of Finkelstein Thompson LLP is investigating claims on behalf of shareholders of Metropolitan Health Networks, Inc. (“Metropolitan” or the “Company”) (NYSE: MDF), concerning the proposed acquisition of the Company by Humana, Inc. Under the terms of the deal, Humana, Inc. will pay $11.25 a share through a tender offer. The total value of the transaction is approximately $850 million. At least one analyst has set a target price for Metropolitan of $13.00 per share.
The investigation is focused on the potential unfairness of the consideration to Metropolitan Health Networks. Inc. shareholders, the process by which the Company's Board of Directors considered the transaction, and potential conflicts of interest among Metropolitan Board members.
If you are interested in discussing your rights as a Metropolitan Health Networks, Inc. shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington D.C. offices at (202)-337-8000 or by email at firstname.lastname@example.org.
Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.
To learn more about Finkelstein Thompson LLP, please visit our website at www.finkelsteinthompson.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Finkelstein Thompson LLP
Rosalee Thomas, 202-337-8000